| Mr Robert J Steffl, RPH | |
|
2708 Bridge Ave, Albert Lea, MN 56007 | |
| (507) 373-1899 | |
| (507) 373-2179 |
| Full Name | Mr Robert J Steffl |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2708 Bridge Ave, Albert Lea, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982741765 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 115889-6 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Robert J Steffl, RPH 1724 Bay Oaks Dr, Albert Lea, MN 56007-4204 Ph: () - | Mr Robert J Steffl, RPH 2708 Bridge Ave, Albert Lea, MN 56007 Ph: (507) 373-1899 |
News Archive
During each cell division, more than 3.3 billion base pairs of genomic DNA have to be duplicated and segregated accurately to daughter cells. But what happens when the DNA template is damaged in such a way that the replication machinery gets stuck? To answer this question, scientists in the team of Matthias Mann at the Max Planck Institute of Biochemistry in Martinsried near Munich, with colleagues in Copenhagen and at Harvard, have analyzed how the protein composition of the DNA replication machinery changes upon encountering damaged DNA.
ViroPharma Incorporated today announced that the European Medicines Agency (EMA) has accepted the filing of its Marketing Authorization Application for Cinryze for acute treatment and prophylaxis against hereditary angioedema, which was submitted through the centralized procedure in March 2010. ViroPharma is seeking European approval for both prevention and treatment of acute attacks of hereditary angioedema.
Echo Therapeutics, Inc., a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, is pleased to announce that its most recently completed clinical study of Symphony was selected for poster presentation at the 74th Scientific Sessions of the American Diabetes Association (ADA) which will be held June 13-17, 2014 in San Francisco, CA.
Beactica, the leading Swedish fragment-based drug discovery company, today announced that it has entered into an agreement with Janssen Research & Development, a division of Janssen Pharmaceutica NV.
WHO and Cambodian health officials are investigating "the source of an unidentified illness" - characterized by high fevers, severe respiratory problems, "and in some cases neurological symptoms" - that has killed more than 60 children in the country since April, NPR's health blog "Shots" reports (Hensley, 7/5). "
› Verified 5 days ago
Stacie Alexandra Neal, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2708 Bridge Ave, Albert Lea, MN 56007 Phone: 507-373-1899 Fax: 507-373-2179 | |
Abbey Hendrickson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1550 Blake Ave, Albert Lea, MN 56007 Phone: 507-377-0668 | |
Mr. Michael Gene White, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1615 West Main St, Albert Lea, MN 56007 Phone: 507-373-6337 Fax: 507-373-1379 | |
John Denow, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2610 Bridge Ave, Albert Lea, MN 56007 Phone: 507-373-9424 Fax: 507-373-0977 | |
Anh Thu Do, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 703 E Main St, Albert Lea, MN 56007 Phone: 507-369-0260 | |
Kelli Fairchild, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 703 E Main St, Albert Lea, MN 56007 Phone: 507-369-0260 Fax: 507-369-0266 | |
Andrew Rozinka, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2610 Bridge Ave, Albert Lea, MN 56007 Phone: 507-373-9424 Fax: 507-373-0977 |